Fosaprepitant

From WikiAnesthesia
Revision as of 01:03, 30 March 2022 by Chris Rishel (talk | contribs) (Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses = | contraindications = | routes = | dosage = |dosage_calculation=fosaprepitant}} Provide a brief summary of this drug here. ==Uses<!-- Describe uses of the drug. If appropriate, add subsections for each indication. -->== ==Contraindications<!-- List contraindications and precautions for use of the drug. -->== ===Absolute contraindications<!-- List absolute contraindications fo...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Fosaprepitant
Clinical data
Dosage
  • 150 mg IV
  • 1 vial of 150 mg/vial
Indication 
Postoperative nausea & vomiting
Route 
Intravenous
Preparation 
150 mg/vial
  1. Murakami C, Kakuta N, Kume K, Sakai Y, Kasai A, Oyama T, Tanaka K, Tsutsumi YM. A Comparison of Fosaprepitant and Ondansetron for Preventing Postoperative Nausea and Vomiting in Moderate to High Risk Patients: A Retrospective Database Analysis. Biomed Res Int. 2017;2017:5703528. doi: 10.1155/2017/5703528. Epub 2017 Dec 19. PMID: 29410964; PMCID: PMC5749222.
Pharmacodynamics
Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References

Top contributors: Chris Rishel

Retrieved from "https://wikianesthesia.org/w/index.php?title=Fosaprepitant&oldid=4394"